These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 8866584)
1. Effect of cessation of short-term therapy with ipratropium bromide on lung function and airway responsiveness. Wilding PJ; Clark MM; Pavord ID; Parker D; Bennett JA; Tattersfield AE Eur Respir J; 1996 Aug; 9(8):1627-31. PubMed ID: 8866584 [TBL] [Abstract][Full Text] [Related]
2. Characterisation of bronchoconstrictor responses to sodium metabisulphite aerosol in atopic subjects with and without asthma. Nichol GM; Nix A; Chung KF; Barnes PJ Thorax; 1989 Dec; 44(12):1009-14. PubMed ID: 2533410 [TBL] [Abstract][Full Text] [Related]
3. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide. de Jong JW; van der Mark TW; Koëter GH; Postma DS Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165 [TBL] [Abstract][Full Text] [Related]
4. Dose related effects of salbutamol and ipratropium bromide on airway calibre and reactivity in subjects with asthma. Britton J; Hanley SP; Garrett HV; Hadfield JW; Tattersfield AE Thorax; 1988 Apr; 43(4):300-5. PubMed ID: 2970125 [TBL] [Abstract][Full Text] [Related]
5. The role of ipratropium bromide in the emergency management of acute asthma exacerbation: a metaanalysis of randomized clinical trials. Stoodley RG; Aaron SD; Dales RE Ann Emerg Med; 1999 Jul; 34(1):8-18. PubMed ID: 10381989 [TBL] [Abstract][Full Text] [Related]
6. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment. Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752 [TBL] [Abstract][Full Text] [Related]
8. The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Lanes SF; Garrett JE; Wentworth CE; Fitzgerald JM; Karpel JP Chest; 1998 Aug; 114(2):365-72. PubMed ID: 9726716 [TBL] [Abstract][Full Text] [Related]
9. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists. van der Woude HJ; Winter TH; Aalbers R Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351 [TBL] [Abstract][Full Text] [Related]
10. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626 [TBL] [Abstract][Full Text] [Related]
11. Asthma control during and after cessation of regular beta 2-agonist treatment. Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655 [TBL] [Abstract][Full Text] [Related]
12. Failure of ipratropium bromide to modify the diurnal variation of asthma in asthmatic children. Sly PD; Landau LI; Olinsky A Thorax; 1987 May; 42(5):357-60. PubMed ID: 2958950 [TBL] [Abstract][Full Text] [Related]
13. Protective effects of inhaled ipratropium bromide on bronchoconstriction induced by adenosine and methacholine in asthma. Crimi N; Palermo F; Oliveri R; Polosa R; Settinieri I; Mistretta A Eur Respir J; 1992 May; 5(5):560-5. PubMed ID: 1535321 [TBL] [Abstract][Full Text] [Related]
14. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group. Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576 [TBL] [Abstract][Full Text] [Related]
15. The influence of ipratropium bromide in the recovery phase of methacholine induced-bronchospasm. Sposato B; Mariotta S; Ricci A; Bruno P; Terzano C; Mannino F Eur Rev Med Pharmacol Sci; 2005; 9(2):117-23. PubMed ID: 15945501 [TBL] [Abstract][Full Text] [Related]
17. Effect of long-term salmeterol therapy compared with as-needed albuterol use on airway hyperresponsiveness. Rosenthal RR; Busse WW; Kemp JP; Baker JW; Kalberg C; Emmett A; Rickard KA Chest; 1999 Sep; 116(3):595-602. PubMed ID: 10492259 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir. Cass LM; Gunawardena KA; Macmahon MM; Bye A Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424 [TBL] [Abstract][Full Text] [Related]
19. Effect of regular terbutaline on the airway response to inhaled budesonide. Wilding PJ; Clark MM; Oborne J; Bennett JA; Tattersfield AE Thorax; 1996 Oct; 51(10):989-92. PubMed ID: 8977598 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic equivalence of a novel HFA134a-containing metered-dose inhaler and the conventional CFC inhaler (Berodual) for the delivery of a fixed combination of fenoterol/ipratropium bromide. A randomized double-blind placebo-controlled crossover study in patients with asthma. Maesen FP; Greefhorst LP; Smeets JJ; Wald FD; Cornelissen PJ Respiration; 1997; 64(4):273-80. PubMed ID: 9257362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]